메뉴 건너뛰기
Psychosomatics
Volumn 47, Issue 6, 2006, Pages 540-541
Ethical impasses in the care of patients with hepatitis C [4]
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA INTERFERON; PROTEINASE INHIBITOR; VIRUS RNA;
EID: 33750466528     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.6.540     Document Type: Letter
Times cited : (5)
References (10)
  • 1
    • 32944480476 scopus 로고    scopus 로고
    • Ethical challenges in the care of persons with hepatitis C infection: A pilot study to enhance informed consent with veterans
    • Geppert CMA, Dettmer E, Jakiche A: Ethical challenges in the care of persons with Hepatitis C infection: a pilot study to enhance informed consent with veterans. Psychosomatics 2005; 46:392-401
    • (2005) Psychosomatics , vol.46 , pp. 392-401
    • Geppert, C.M.A.1    Dettmer, E.2    Jakiche, A.3
  • 2
    • 28944451441 scopus 로고    scopus 로고
    • α treatment of hepatitis C patients with psychiatric illness: Evidence-based risk-benefit assessment
    • α treatment of hepatitis C patients with psychiatric illness: evidence-based risk-benefit assessment. Prim Care Companion J Clin Psychiatry 2005; 7:74-75
    • (2005) Prim Care Companion J Clin Psychiatry , vol.7 , pp. 74-75
    • Rifai, M.A.1
  • 3
    • 24144458304 scopus 로고    scopus 로고
    • Interferon, treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment
    • author reply: 721-712
    • Rifai MA, Loftis JM, Hauser P: Interferon, treatment of patients with hepatitis C: the role of a comprehensive risk-benefit assessment. CNS Drugs 2005; 19:719-721: author reply: 721-712
    • (2005) CNS Drugs , vol.19 , pp. 719-721
    • Rifai, M.A.1    Loftis, J.M.2    Hauser, P.3
  • 4
    • 0642303165 scopus 로고    scopus 로고
    • The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
    • el-Serag HB, Davila JA, Petersen NJ, et al: The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139:817-823
    • (2003) Ann Intern Med , vol.139 , pp. 817-823
    • El-Serag, H.B.1    Davila, J.A.2    Petersen, N.J.3
  • 5
    • 1542358091 scopus 로고    scopus 로고
    • Screening for hepatitis C virus infection: A review of the evidence of the U.S. Preventive Services Task Force
    • Chou R, Clark EC, Helfand M: Screening for hepatitis C virus infection: a review of the evidence of the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140:465-479
    • (2004) Ann Intern Med , vol.140 , pp. 465-479
    • Chou, R.1    Clark, E.C.2    Helfand, M.3
  • 6
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • Strader D, Wright T, Thomas DL, et al: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147-1171
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.1    Wright, T.2    Thomas, D.L.3
  • 7
    • 0036828840 scopus 로고    scopus 로고
    • Management of Hepatitis C: 2002
    • National Institutes of Health Consensus Development Conference Statement
    • National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002. Hepatology 2002; 36:S3-S20
    • (2002) Hepatology , vol.36
  • 8
    • 0034759752 scopus 로고    scopus 로고
    • Psychiatric comorbidity among hepatitis C-positive patients
    • Yovtcheva SP, Rifai MA, Moles JK, et al: Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42:411-415
    • (2001) Psychosomatics , vol.42 , pp. 411-415
    • Yovtcheva, S.P.1    Rifai, M.A.2    Moles, J.K.3
  • 9
    • 9744237988 scopus 로고    scopus 로고
    • Interferon for hepatitis C patients with psychiatric disorders
    • Rifai MA, Bozorg B, Rosenstein DL: Interferon for hepatitis C patients with psychiatric disorders. Am J Psychiatry 2004; 161:2331-2332
    • (2004) Am J Psychiatry , vol.161 , pp. 2331-2332
    • Rifai, M.A.1    Bozorg, B.2    Rosenstein, D.L.3
  • 10
    • 33750483872 scopus 로고    scopus 로고
    • Interferon treatment of hepatitis C patients with psychiatric disorders: Evidence-based, risk-benefit assessment
    • Rifai MA, Rosenstein DL: Interferon treatment of hepatitis C patients with psychiatric disorders: evidence-based, risk-benefit assessment. Psychosomatics 2005; 46:165-166
    • (2005) Psychosomatics , vol.46 , pp. 165-166
    • Rifai, M.A.1    Rosenstein, D.L.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.